A new type of gene therapy that rewires nerve cells in the eye has given a blind man some limited vision. The 58-year-old man has a genetic disease called retinitis pigmentosa, which causes ...

Please provide your email address to receive an email when new articles are posted on . More than half of patients with severe retinitis pigmentosa who received the Alpha IMS subretinal implant ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. MCO-010 yielded sustained vision improvements in ...

CHICAGO -- A mutation-agnostic gene therapy for retinitis pigmentosa (RP) showed promise for improving vision in severely vision-impaired and blind patients, a randomized clinical trial showed. After ...

Three years ago, a team announced that they had cured X-linked retinitis pigmentosa, a blinding retinal disease, in dogs. Now they've shown that they can cure the canine disease over the long term, ...

According to a new scientific breakthrough, a device - a tiny, three-by-three millimetre microchip, has allowed patients with inherited blindness to detect objects with their eyes, unlike a rival ...

May 9, 2012 — A subretinal microchip implant has entered new clinical trials in the United Kingdom and Hong Kong, and early results are encouraging, according to researchers from 2 studies. An earlier ...

Add Yahoo as a preferred source to see more of our stories on Google. Sadly, there's a high chance that her condition will eventually lead to sight loss—something she's hopeful her future partner will ...

What is retinitis pigmentosa (RP) and how does it lead to blindness? Retinitis pigmentosa (RP) is a progressive eye disease that leads to untreatable blindness. The name of the disease derives from ...

Researchers have discovered that the absence of Adiponectin receptor 1 protein (AdipoR1), one of the principal enzymes regulating ceramide homeostasis in the retina, leads to an accumulation of ...